519606 — Integrated Proteins Income Statement
0.000.00%
- IN₹2.36bn
- IN₹2.36bn
- IN₹99.41m
Annual income statement for Integrated Proteins, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 1.67 | 2.37 | 215 | 99.4 |
| Cost of Revenue | ||||
| Gross Profit | 0.2 | 0.151 | 4.71 | 4.39 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 2.81 | 3.83 | 214 | 96.6 |
| Operating Profit | -1.14 | -1.45 | 0.82 | 2.83 |
| Total Net Non Operating Interest Income / Expense | ||||
| Gain / Loss on Sale of Assets | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 0.418 | 1.04 | 3.19 | 2.83 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 0.309 | 0.893 | 2.5 | 2.25 |
| Net Income Before Extraordinary Items | ||||
| Net Income | 0.309 | 0.893 | 2.5 | 2.25 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | 0.309 | 0.893 | 2.5 | 2.25 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 0.01 | 0.003 | 0.054 | 0.012 |